October 2023 in “bioRxiv (Cold Spring Harbor Laboratory)”
This study demonstrated that disrupting EGFR signaling in mice leads to immune sensitivity compromising the hairfollicle's protective environment, but JAK1/2 inhibition can restore this immune privilege and stimulate hair growth, suggesting a potential therapy for scarring hair loss diseases like cicatricial alopecia.
48 citations
,
May 2018 in “Expert Opinion on Therapeutic Targets”
This review discusses how modern lifestyle factors affecting gut health may contribute to Alopecia Areata in genetically predisposed individuals, reporting no new results but suggesting the need for long-term interventions.
2 citations
,
February 2014 in “Hair therapy & transplantation”
This article reviews the autoimmune mechanism and potential environmental triggers of alopecia areata, focusing on cytokines, but does not provide new research findings.
89 citations
,
October 1996 in “Dermatologic Clinics”
This review discusses androgenetic alopecia and alopecia areata through a systems biology lens, emphasizing the role of multi-omics data integration to explore molecular mechanisms and potential therapeutic strategies, but offers no new clinical results.
A permanent hair loss solution could involve reprogramming hairfollicles to resist DHT using mRNA and siRNA. However, high costs, safety concerns, and the pharmaceutical industry's preference for ongoing treatments over one-time cures are major obstacles, with finasteride and minoxidil remaining standard treatments.
Age affects hair loss severity and treatment effectiveness, with younger individuals often experiencing more aggressive loss but potentially better regrowth due to less follicle miniaturization. Treatments like finasteride and minoxidil are commonly used, and early intervention is crucial for better outcomes.
DHT is not the only cause of male pattern hair loss; genetic sensitivity, inflammation, and fibrosis also contribute. GHK-Cu, a copper peptide, is being explored as an alternative treatment to finasteride and minoxidil, showing potential in improving follicle health.
Accutane may accelerate hair loss in genetically predisposed individuals by affecting enzymes related to DHT metabolism. Some users report hair loss after taking Accutane, while others use treatments like finasteride and minoxidil to manage hair loss.